Literature DB >> 14573797

Role of sialic acid-containing molecules and the alpha4beta1 integrin receptor in the early steps of polyomavirus infection.

Maddalena Caruso1, Michaela Cavaldesi1, Massimo Gentile2, Olga Sthandier1, Paolo Amati1, Marie-Isabelle Garcia1.   

Abstract

Murine polyomavirus (MPyV) infection occurs through recognition of sialic acid (SA) residues present on the host cell membrane, but the nature of the molecules involved and the exact role of this interaction in virus cell entry still need to be clarified. In this work, mutations at residues R(77) or H(298) of the MPyV VP1 protein were shown to lead to a complete loss of virus infectivity, which, however, could be restored by lipofection of virus particles into the cytoplasm of the host cells. Using virus-like particles (VLPs), it was demonstrated that the non-infectivity of these mutants was due to impaired cell entry caused by total abrogation of SA-dependent cell binding. This indicates that SA residues are essential primary cell receptors for MPyV. As the alpha4beta1 integrin has been identified recently as a cell receptor for MPyV, the relationship, if any, was investigated between SA-containing and alpha4beta1 integrin receptors. The ability of mutants R(77)Q and H(298)Q and wt VLPs to bind to cells overexpressing the alpha4beta1 integrin was studied in SA-positive (BALB/c 3T3 cells and Pro-5 cells) and SA-deficient (Pro5-derived Lec-2 cells) backgrounds. Overexpression of alpha4beta1 integrin did not restore binding of mutant VLPs in any of these cell lines or, indeed, that of wt VLPs in a SA-deficient background. Moreover, evidence is provided that overexpression of the sialylated alpha4beta1 integrin enhances wt VLP cell binding, suggesting that, in addition to its function at a post-attachment level, alpha4beta1 integrin acts also as one of the SA-containing receptors for initial cell binding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573797     DOI: 10.1099/vir.0.19369-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

Review 1.  The role of sialic acid in human polyomavirus infections.

Authors:  Gretchen V Gee; Aisling S Dugan; Natia Tsomaia; Dale F Mierke; Walter J Atwood
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

2.  Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patients.

Authors:  Anat Achiron; Gadi Miron; Rina Zilkha-Falb; David Magalashvili; Mark Dolev; Yael Stern; Michael Gurevich
Journal:  J Neurovirol       Date:  2016-05-11       Impact factor: 2.643

3.  Uptake pathway of polyomavirus via ganglioside GD1a.

Authors:  Joanna Gilbert; Thomas Benjamin
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Ganglioside and Non-ganglioside Mediated Host Responses to the Mouse Polyomavirus.

Authors:  John You; Samantha D O'Hara; Palanivel Velupillai; Sherry Castle; Steven Levery; Robert L Garcea; Thomas Benjamin
Journal:  PLoS Pathog       Date:  2015-10-16       Impact factor: 6.823

Review 5.  Taking the Scenic Route: Polyomaviruses Utilize Multiple Pathways to Reach the Same Destination.

Authors:  Colleen L Mayberry; Melissa S Maginnis
Journal:  Viruses       Date:  2020-10-15       Impact factor: 5.048

6.  Antibody escape by polyomavirus capsid mutation facilitates neurovirulence.

Authors:  Matthew D Lauver; Daniel J Goetschius; Colleen S Netherby-Winslow; Katelyn N Ayers; Ge Jin; Daniel G Haas; Elizabeth L Frost; Sung Hyun Cho; Carol M Bator; Stephanie M Bywaters; Neil D Christensen; Susan L Hafenstein; Aron E Lukacher
Journal:  Elife       Date:  2020-09-17       Impact factor: 8.140

7.  Amino Acid Sequences Mediating Vascular Cell Adhesion Molecule 1 Binding to Integrin Alpha 4: Homologous DSP Sequence Found for JC Polyoma VP1 Coat Protein.

Authors:  Michael Andrew Meyer
Journal:  Neurol Int       Date:  2013-07-22

Review 8.  Microtubules in Polyomavirus Infection.

Authors:  Lenka Horníková; Kateřina Bruštíková; Jitka Forstová
Journal:  Viruses       Date:  2020-01-18       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.